Usfda, Federal agency

Washington, Sep 20 US health officials have voiced their support for the recommendation from the Food and Drug Administration (FDA) advisory panel that Covid-19 booster shots be limited to those 65 years and older and individuals at high risk, with some hoping for a broader use of the jabs at a later date.National Institutes of Health Director Francis Collins told Fox News on Sunday that the guidance issued two days ago by the FDA panel is in line with what the US administration planned for a booster rollout, though not identical, reports Xinhua news agency."I think there's less difference between where we were in the middle of August and what the advisory committee said this past Friday," he said.The administration announced in August that a rollout plan was being put in place for booster shots that would be initiated September 20, but also specified that the plan itself was pending recommendations from the FDA.The people eligible for a booster would be those who received their second dose six or eight months earlier.Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told NBC News on Sunday that the plan initially announced by the White House is in line with the advisory panel's recommendation.Ultimately, he thought the "proper regimen" will include the original two shots plus a booster for everyone, though it may not be necessary right now."You want to do that according to what the data tells you, including the risk-benefit ratio, particularly for the younger people who do not generally get as much severe disease as the elderly and others," Fauci said."So, I believe that there's a good chance that as we get into the coming months, into the next year, that you will see the data pointing to the benefit of having a much broader blanket of people."A decision about boosters from the FDA is expected by this week, and an advisory committee of the Centers for Disease Control and Prevention (CDC) is slated to meet on Wednesday and Thursday to recommend how a third shot should be used.The FDA advisory committee, following Pfizer's lead, recommended that the third shot be given at least six months after the second.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

UsfdaFOLLOW

Usfda, Latest News

India-based pharma giant, Zydus Cadila received final approval from USFDA for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach. ...

Washington, Nov 1 US drugmaker Moderna has confirmed that the Food and Drug Administration (FDA) has delayed granting ... ...

Washington, Oct 23 Pfizer and its partner BioNTech said their Covid-19 vaccine is safe and 90.7 per cent ... ...

The United States will allow entry only to those foreign nationals who have been fully immunised with a coronavirus vaccine that has been approved either by the Food and Drug Administration (FDA) or the World Health Organization (WHO), the State Depa ...

Los Angeles, Oct 2 California became the first state in the United States to announce plans to require ... ...

Aurangabad, Sept 30: Sellers of sweets, edible oils and other food items are required to obtain a license from ... ...

Aurangabad, Sept 29: A pharmacist is an important component of the health system and his work and contribution touches ... ...

Washington, Sep 20 US health officials have voiced their support for the recommendation from the Food and Drug ... ...